logo

Last Update

This profile was last updated on 7/31/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Harry Wilcox?

Harry W. Wilcox

General Partner and Chief Operating Officer

Flagship Ventures

HQ Phone:  (617) 868-1888

Direct Phone: (617) ***-****direct phone

Email: h***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Flagship Ventures

55 Cambridge Parkway Suite 800E

Cambridge, Massachusetts,02142

United States

Company Description

Realizing entrepreneurial innovation is the mission of Flagship Ventures. Founded in 2000, the firm has launched more than 35 first-in-class companies while investing in another 55. Flagship manages over $1.4 billion in capital and is active in three principal...more

Background Information

Employment History

Chief Financial Officer and Senior Vice President Corporate Development

EXACT Sciences Corporation


President and Chief Executive Officer

Cambridge NeuroScience , Inc.


Executive Vice President, Chief of Finance and Corporate Development

Pyrosequencing AB


Founding Chief Financial Officer and General Partner

Highland Capital Partners Inc


Partner

Beacon Biomedicine


Senior Positions

Charles River Ventures Inc


Affiliations

Quantum Designs LLC

Board Member


Accuri Cytometers , Inc.

Board Member


T2 Biosystems, Inc.

Board Member


Celexion LLC.

Board Member


Seventh Sense Biosystems Inc

Board Member


BG Medicine Inc

Board Member


Selventa

Board Member


Be Power Tech, Inc.

Board Member


Midori Renewables Inc

Board Member


Seahorse Bioscience Inc

Board Member


Tangent Medical Technologies Inc

Board Member


Black Duck Software Inc

Board Member


HN Company , Inc.

Board Member


Non-Employee

Board Member


Regional Technology Development Corp

Board Member


Chief Financial Officer and General Partner

Founder


Education

BS

finance

University of Arizona


M.B.A.

Boston University


Web References(111 Total References)


ABOUT QUANTUM DESIGNS - Quantum Designs

quantumdesigns.com [cached]

Harry Wilcox
Chief Operating Officer and General Partner, Flagship Ventures


Pioneering Ventures for Life - Flagship Pioneering

flagshippioneering.com [cached]

Harry Wilcox
Harry Wilcox General Partner


2016 Agenda - Convergence Forum

convergenceforum.com [cached]

Speaker: Harry Wilcox, COO and General Partner, Flagship Ventures
Harry Wilcox Harry joined Flagship Ventures in 2006, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. In addition to his corporate experience, Harry was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures. Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies. In addition to EXACT Sciences, Harry led an active consulting practice which included roles as interim CEO of two biotech companies: Thrasos Therapeutics and Biostratum. Prior to this, Harry was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held European biotech company. Earlier, he had been the President and Chief Executive Officer of Cambridge NeuroScience, Inc. (NASDAQ:CNSI) until its sale to CeNeS Pharmaceuticals, and before that Sr. VP Business Development and CFO of Cellcor. As COO and General Partner at Flagship Ventures, Harry is responsible for the operational management of Flagship, serves as a member of Flagship's investment committee, and oversees the firm's operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech.


Old hands, young scientists team up to bring products to market - Pilot Communications Group, LLC

pilotcommsgroup.com [cached]

Harry Wilcox, a general partner at Flagship, said his firm typically backs biotech, medical device, and renewable energy companies, but was intrigued by the food inventions developed by MIT scientist David Edwards.
Venture capital firms have invested a total of about $25 million in the company, Wilcox said. "There's a real need for food without allergens," he added. "Clean food."


About Us > Management Team

midorihealth.com [cached]

Harry Wilcox
Harry Wilcox , CEO and Chairman, COO Flagship Pioneering As COO and general partner at Flagship Pioneering, Harry is responsible for the operational management of Flagship, serves as a member of Flagship's investment committee, and oversees the firm's operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech. Harry Wilcox Harry Wilcox , CEO and Chairman, COO Flagship Pioneering As COO and general partner at Flagship Pioneering, Harry is responsible for the operational management of Flagship, serves as a member of Flagship's investment committee, and oversees the firm's operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson and of Seahorse BioScience prior to its successful sale to Agilent Technologies. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Seventh Sense Biosystems, T2 Biosystems (NASDAQ:TTOO), Quantum Designs, Inc (Chairman), Selventa, Inc., MidoriUSA (Acting CEO), HN Company, Inc. (Chairman and acting CEO), BG Medicine, Inc. and Be Power Tech.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory